This week, we’re back for more coverage of the 2021 Gastrointestinal Cancers Symposium, hearing about the FIGHT trial in advanced gastric/gastroesophageal junction adenocarcinoma, the ClarIDHy study in IDH1-mutated cholangiocarcinoma, and the POLO trial in BRCA-mutated pancreatic cancer.

This week, we’re back for more coverage of the 2021 Gastrointestinal Cancers Symposium, hearing about the FIGHT trial in advanced gastric/gastroesophageal junction adenocarcinoma, the ClarIDHy study in IDH1-mutated cholangiocarcinoma, and the POLO trial in BRCA-mutated pancreatic cancer.

This week, we’re back for more coverage of the 2021 Gastrointestinal Cancers Symposium, hearing about the FIGHT trial in advanced gastric/gastroesophageal junction adenocarcinoma, the ClarIDHy study in&nbsp;IDH1-mutated cholangiocarcinoma, and the POLO trial in&nbsp;BRCA-mutated pancreatic cancer.

More From GI21: Findings in Gastric Cancer, Cholangiocarcinoma, and Pancreatic Cancer

News and views from the world of clinical oncology and hematology.

Share More From GI21: Findings in Gastric Cancer, Cholangiocarcinoma, and Pancreatic Cancer

Sign up to save your podcasts

More From GI21: Findings in Gastric Cancer, Cholangiocarcinoma, and Pancreatic Cancer

More From GI21: Findings in Gastric Cancer, Cholangiocarcinoma, and Pancreatic Cancer

More shows like The ASCO Post Podcast

Research To Practice | Oncology Videos

ASCO Daily News